<table frame="border" width="85%" xmlns="urn:hl7-org:v3" xmlns:voc="urn:hl7-org:v3/voc" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<tbody>
<tr>
<td align="center" colspan="2" rowspan="1" valign="top">Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (<linkhtml href="#ID_dc11c121-07fb-4cf0-d244-b87062f67744">2.6</linkhtml>, <linkhtml href="#ID_6c3cabe8-4496-de93-0695-4a280f3455f9">5.1</linkhtml>, <linkhtml href="#ID_64140f24-2175-4bf9-3145-35f3e0c9fd48">7</linkhtml>, <linkhtml href="#ID_e2604d1e-f8fb-f51a-bff0-34c3dea4a0ee">12.3</linkhtml>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<paragraph>Interacting Agents</paragraph>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<paragraph>Prescribing Recommendations</paragraph>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<paragraph>Cyclosporine, HIV protease inhibitors (tipranavir plus ritonavir), hepatitis C protease inhibitor (telaprevir)</paragraph>
</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">Avoid atorvastatin<paragraph></paragraph>
</td>
</tr>
<tr>
<td align="left" colspan="1" valign="top">HIV protease inhibitor (lopinavir plus ritonavir)</td>
<td align="left" colspan="1" valign="top">Use with caution and lowest dose necessary</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<paragraph>Clarithromycin, itraconazole, HIV protease inhibitors (saquinavir plus ritonavir, darunavir plus ritonavir, fosamprenavir, fosamprenavir plus ritonavir) </paragraph>
</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Do not exceed 20 mg atorvastatin daily<paragraph></paragraph>
</td>
</tr>
<tr>
<td align="left" colspan="1" valign="top">HIV protease inhibitor (nelfinavir) <br/>Hepatitis C protease inhibitor (boceprevir)</td>
<td align="left" colspan="1" valign="top">Do not exceed 40 mg atorvastatin daily</td>
</tr>
</tbody>
</table>